医学
前列腺切除术
指南
前列腺癌
放射治疗
生化复发
小心等待
系统回顾
梅德林
挽救疗法
癌症
前列腺癌的治疗
肿瘤科
重症监护医学
医学物理学
内科学
化疗
病理
政治学
法学
作者
Todd M. Morgan,Stephen A. Boorjian,Mark K. Buyyounouski,Brian F. Chapin,David Y.T. Chen,Heather H. Cheng,Roger Chou,Heather A. Jacene,Sophia C. Kamran,Sennett K. Kim,Erin Kirkby,Amy N. Luckenbaugh,B.J. Nathanson,Yaw A. Nyame,Edwin M. Posadas,Phuoc T. Tran,Ronald C. Chen
标识
DOI:10.1097/ju.0000000000003892
摘要
The summary presented herein covers recommendations on salvage therapy for recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for patients who have experienced a recurrence following prior treatment with curative intent. This is Part I of a three-part series focusing on treatment decision-making at the time of suspected biochemical recurrence (BCR) after radical prostatectomy (RP). Please refer to Part II for discussion of treatment delivery for non-metastatic BCR after RP and Part III for discussion of evaluation and management of recurrence after radiotherapy (RT) and focal therapy, regional recurrence, and oligometastasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI